study: ADMC_ADNI2-GO species: Human studyName: The Alzheimer's Disease Metabolomics Consortium Alzheimers Disease Neuroimaging Initiative 2-GO (ADMC_ADNI2-GO) Study studyType: Individual consortium: AMP-AD dataTypeAll: Clinical, Metabolomics isModelSystem: false studyDescription: This study generated metabolomics data on the Alzheimer's Disease Neuroimaging Initiative (ADNI) multi-center longitudinal cohort study. The ADNI2-GO cohort includes approximately 150 cognitively normal patients (CN), 150 patients diagnosed with early mild cognitive impairment (MCI), 150 patients diagnosed with late mild cognitive impairment (MCI), and 200 patients diagnosed with mild probable AD. syn22024808